Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2016 | Pages:
85 | Publisher: Hexa Research
Industry: Energy | Report Format: Electronic (PDF)
The global glucose biosensor market is expected to witness a healthy and rapid growth over the forecast period (from 2015 to 2022). The increasing diabetes rates across the globe are anticipated to the key growth driving factor for the market. The other market growth driving factors are the rising popularity of non-invasive products, the increased needs for early diabetes detection & diabetes awareness levels amongst people, constantly evolving and technically better-quality products etc. The advent of technical advancements is also projected to play an important role in increasing the product usage rates. Moreover, many companies, including big and small, are involved in extensive Research & Development (R&D) initiatives to develop more accurate, cost-effective, reliable, and less painful products. However, on the contrary, the presence of a number of other diabetes management methods, for instance, lab methods for monitoring the blood glucose levels, is said to hamper the market growth. The global market is divided into end-uses, applications, and regions. Based on on-uses, the glucose biosensor market is segregated as hospitals, home care diagnostics, and others like research institutes, diagnostic labs, & clinical. The home care diagnostics end-use sector dominated the global market in 2015. This sector includes the use of point-of-care-test (POCT) equipment like hand-held glucose meters. All these POCT equipment are cost-effective and user-friendly providing quick results. In contrast, the hospital end-use sector is also said to witness a rapid growth growing at a healthy compound annual growth rate (CAGR) in the near future. The regions analyzed here are the Middle East & Africa (MEA), Latin America, Europe, North America, and Asia-Pacific (APAC). The North America region dominated the global market accounting for the biggest market share in 2015. Also, the region is expected to maintain the trend over the next seven years. The APAC region is also likely to experience a tremendous growth with a healthy CAGR in the near future. The developing nations such as India & China are anticipated to boost the regional market growth owing to the rising occurrences of diabetes in the regions. The key market participants of the glucose biosensor market are Bayer, Abbott, Roche, etc. These market players are involved in brand new product launches & developments, joint ventures, collaborations, and partnerships to register their growth and ensure sustainability in the market.
Table of Content Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. Glucose biosensors Market - Industry Summary and Key Buying Criteria, 2012 - 2020 Chapter 3. Glucose biosensors Industry Outlook 3.1. Market segmentation 3.2. Market size and growth prospects, 2012-2020 3.3. Glucose biosensors: Market dynamics 3.3.1. Market driver analysis 3.3.1.1. Rising prevalence of diabetes 3.3.1.2. Presence of a strong range of products in pipeline 3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity 3.3.2. Market restraint analysis 3.3.2.1. Presence of alternative methods 3.4. Glucose biosensors market: Industry trend analysis 3.5. Glucose biosensors Market - PESTEL Analysis 3.6. Glucose biosensors Industry analysis - Porter's Five Forces Model 3.7. Glucose biosensors: Company Market Share Analysis (%), 2014 3.8. Key opportunities prioritized Chapter 4. Glucose Biosensors End-User Application Outlook 4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2014 & 2022 4.2. Hospital 4.2.1. Hospital market revenue, by region, 2012 to 2022 (USD Million) 4.3. Homecare Diagnostics 4.3.1. Homecare diagnostics market revenue, by region, 2012 to 2022 (USD Million) 4.4. Others 4.4.1. Others market revenue, by region, 2012 to 2022 (USD Million) Chapter 5. Glucose Biosensors Regional Outlook 5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2014 & 2022 5.2. North America 5.2.1. U.S. 5.2.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.2.2. Canada 5.2.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.3. Europe 5.3.1. Germany 5.3.1.1. glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.3.2. U.K. 5.3.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.3.3. Rest of Europe 5.3.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.4. Asia Pacific 5.4.1. China 5.4.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.4.2. India 5.4.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.4.3. Rest of Asia Pacific 5.4.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.5. MEA 5.5.1. South Africa 5.5.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.5.2. Saudi Arabia 5.5.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.5.3. Rest of MEA 5.5.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.6. Latin America 5.6.1. Brazil 5.6.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.6.2. Mexico 5.6.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) 5.6.3. Rest of Latin America 5.6.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million) Chapter 6. Competitive Landscape 6.1. Roche Diagnostics 6.1.1. Company Overview 6.1.2. Financial Performance 6.1.3. Product Benchmarking 6.1.4. Strategic Initiatives 6.2. LifeScan Inc. 6.2.1. Company Overview 6.2.2. Financial Performance 6.2.3. Product Benchmarking 6.2.4. Strategic Initiatives 6.3. Abbott Laboratories 6.3.1. Company Overview 6.3.2. Financial Performance 6.3.3. Product Benchmarking 6.3.4. Strategic Initiatives 6.4. Bayer 6.4.1. Company Overview 6.4.2. Financial Performance 6.4.3. Product Benchmarking 6.4.4. Strategic Initiatives 6.5. Medtronic Inc. 6.5.1. Company Overview 6.5.2. Financial Performance 6.5.3. Product Benchmarking 6.5.4. Strategic Initiatives 6.6. Pinnacle Medical Solutions Inc. 6.6.1. Company Overview 6.6.2. Financial Performance 6.6.3. Product Benchmarking 6.6.4. Strategic Initiatives 6.7. AgaMatrix Inc. 6.7.1. Company Overview 6.7.2. Financial Performance 6.7.3. Product Benchmarking 6.7.4. Strategic Initiatives 6.8. Sanofi S.A. 6.8.1. Company Overview 6.8.2. Financial Performance 6.8.3. Product Benchmarking 6.8.4. Strategic Initiatives 6.9. BioSense Medical Devices, LLC 6.9.1. Company Overview 6.9.2. Financial Performance 6.9.3. Product Benchmarking 6.9.4. Strategic Initiatives 6.10. Nova Biomedical 6.10.1. Company Overview 6.10.2. Financial Performance 6.10.3. Product Benchmarking 6.10.4. Strategic Initiatives
List of Tables 1. Glucose Biosensors - Industry Snapshot & Key Buying Criteria, 2012 - 2022 2. Global glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 3. Global glucose biosensors market, by region, 2012 - 2022 (USD Million) 4. Glucose Biosensors - Key Market Driver Analysis 5. Glucose Biosensors - Key Market Restraint Analysis 6. North America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 7. U.S. glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 8. Canada glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 9. Europe glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 10. Germany glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 11. U.K. glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 12. Rest of Europe glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 13. Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 14. China glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 15. India glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 16. Rest of Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 17. Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 18. Brazil glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 19. Mexico glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 20. Rest of Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 21. MEA glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 22. South Africa glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 23. Saudi Arabia glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million) 24. Rest of MEA glucose biosensors market revenue, by end-user application, 2012 - 2022 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
